These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34183705)

  • 21. Female gender is associated with long COVID syndrome: a prospective cohort study.
    Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD
    Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long COVID in a prospective cohort of home-isolated patients.
    Blomberg B; Mohn KG; Brokstad KA; Zhou F; Linchausen DW; Hansen BA; Lartey S; Onyango TB; Kuwelker K; Sævik M; Bartsch H; Tøndel C; Kittang BR; ; Cox RJ; Langeland N
    Nat Med; 2021 Sep; 27(9):1607-1613. PubMed ID: 34163090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study.
    Khan SM; Shilen A; Heslin KM; Ishimwe P; Allen AM; Jacobs ET; Farland LV
    Am J Obstet Gynecol; 2022 Feb; 226(2):270-273. PubMed ID: 34555320
    [No Abstract]   [Full Text] [Related]  

  • 24. Post COVID syndrome: a new challenge for medicine.
    Tirelli U; Taibi R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4422-4425. PubMed ID: 34227079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection.
    Yang Y; Hu X; Xiong L; Fu P; Feng W; Li W; Zhang L; Sun F
    BMC Infect Dis; 2021 Feb; 21(1):141. PubMed ID: 33535989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study.
    García-Abellán J; Padilla S; Fernández-González M; García JA; Agulló V; Andreo M; Ruiz S; Galiana A; Gutiérrez F; Masiá M
    J Clin Immunol; 2021 Oct; 41(7):1490-1501. PubMed ID: 34273064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.
    Mahmud R; Rahman MM; Rassel MA; Monayem FB; Sayeed SKJB; Islam MS; Islam MM
    PLoS One; 2021; 16(4):e0249644. PubMed ID: 33831043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
    Molteni E; Sudre CH; Canas LS; Bhopal SS; Hughes RC; Antonelli M; Murray B; Kläser K; Kerfoot E; Chen L; Deng J; Hu C; Selvachandran S; Read K; Capdevila Pujol J; Hammers A; Spector TD; Ourselin S; Steves CJ; Modat M; Absoud M; Duncan EL
    Lancet Child Adolesc Health; 2021 Oct; 5(10):708-718. PubMed ID: 34358472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.
    Harrington WE; Trakhimets O; Andrade DV; Dambrauskas N; Raappana A; Jiang Y; Houck J; Selman W; Yang A; Vigdorovich V; Yeung W; Haglund M; Wallner J; Oldroyd A; Hardy S; Stewart SWA; Gervassi A; Van Voorhis W; Frenkel L; Sather DN
    Cell Rep Med; 2021 Apr; 2(4):100253. PubMed ID: 33842901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Fatigue in Long COVID: Web-Based Quantitative Follow-up Study in Members of Online Long COVID Support Groups.
    Van Herck M; Goërtz YMJ; Houben-Wilke S; Machado FVC; Meys R; Delbressine JM; Vaes AW; Burtin C; Posthuma R; Franssen FME; Hajian B; Vijlbrief H; Spies Y; van 't Hul AJ; Janssen DJA; Spruit MA
    J Med Internet Res; 2021 Sep; 23(9):e30274. PubMed ID: 34494964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
    Liang L; Yang B; Jiang N; Fu W; He X; Zhou Y; Ma WL; Wang X
    J Korean Med Sci; 2020 Dec; 35(47):e418. PubMed ID: 33289374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: an observational cohort study.
    Al Mutair A; Alhumaid S; Alhuqbani WN; Zaidi ARZ; Alkoraisi S; Al-Subaie MF; AlHindi AM; Abogosh AK; Alrasheed AK; Alsharafi AA; Alhuqbani MN; Alhowar NA; Salih S; Alhedaithy MA; Al-Tawfiq JA; Al-Shammari H; Abdulqawi R; Ismail AF; Hamdan N; Saad F; Olhaye FA; Eltahir TA; Rabaan AA; Al-Omari A
    Eur J Med Res; 2020 Nov; 25(1):61. PubMed ID: 33239068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management.
    Raveendran AV; Misra A
    Diabetes Metab Syndr; 2021; 15(5):102235. PubMed ID: 34384972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposed integrative model for post-COVID symptoms.
    Fernández-de-Las-Peñas C; Florencio LL; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Raveendran AV
    Diabetes Metab Syndr; 2021; 15(4):102159. PubMed ID: 34186367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Common is Long COVID in Children and Adolescents?
    Zimmermann P; Pittet LF; Curtis N
    Pediatr Infect Dis J; 2021 Dec; 40(12):e482-e487. PubMed ID: 34870392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.
    Townsend L; Dyer AH; Jones K; Dunne J; Mooney A; Gaffney F; O'Connor L; Leavy D; O'Brien K; Dowds J; Sugrue JA; Hopkins D; Martin-Loeches I; Ni Cheallaigh C; Nadarajan P; McLaughlin AM; Bourke NM; Bergin C; O'Farrelly C; Bannan C; Conlon N
    PLoS One; 2020; 15(11):e0240784. PubMed ID: 33166287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status.
    Xie Y; Bowe B; Al-Aly Z
    Nat Commun; 2021 Nov; 12(1):6571. PubMed ID: 34772922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
    Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
    Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.